Opsona

closed

Leader in drug development in immunology research - Ireland.

Launch date

2004

Employees

Market cap

Enterprise valuation

€165m (Public information from Dec 2016)

Dublin County Dublin (HQ)

Date	Investors	Amount	Round
-	Omnes Capital Seroba Life Sciences Sunstone Technology Ventures BB Biotech	N/A	-
Feb 2005	Enterprise Ireland INventages Venture Capital	$6.6m	Series A
Feb 2009*	N/A	€18.0m	Series B
Jun 2009	Enterprise Ireland Fountain Healthcare Partners INventages Venture Capital Novartis Venture Fund	$4.6m	Series B
Apr 2013	Heartcore Capital Enterprise Ireland Baxter Ventures Amgen EMBL Ventures Amgen Ventures BB Biotech Ventures Novartis Venture Fund	€33.0m	Series C
Oct 2013	Amgen Ventures	€3.0m Valuation: €165m	Series C
Dec 2016	Heartcore Capital Seroba Kernel Fountain Healthcare Partners Roche Venture Fund EMBL Ventures BB Biotech Ventures Novartis Venture Fund	€15.3m Valuation: €165m	Late VC
Total Funding		€79.5m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Opsona